HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 172 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $668,882 | +99.1% | 17,510 | +129.2% | 0.20% | +17.9% |
| Q2 2022 | $336,000 | +122.5% | 7,639 | -25.9% | 0.17% | +110.0% |
| Q4 2018 | $151,000 | -53.7% | 10,313 | -42.6% | 0.08% | -43.7% |
| Q3 2018 | $326,000 | +34.2% | 17,965 | +44.5% | 0.14% | +140.7% |
| Q1 2018 | $243,000 | -68.7% | 12,429 | -67.6% | 0.06% | -74.1% |
| Q4 2017 | $777,000 | +164.3% | 38,345 | +126.9% | 0.23% | +174.7% |
| Q3 2017 | $294,000 | – | 16,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |